Global Cancer Diagnostics Market Growth 2018-2023

Publisher Name :
Date: 19-Oct-2018
No. of pages: 134

This report manily covers cancer diagnostics market.Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.

North America is expected to account for the largest share in the cancer diagnostics market, followed by Europe and Asia.

The Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies operating in the cancer diagnostics market.

Over the next five years, LPI(LP Information) projects that Cancer Diagnostics will register a 12.7% CAGR in terms of revenue, reach US$ 18400 million by 2023, from US$ 8990 million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Cancer Diagnostics market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Diagnostics market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- Platform-based

- Instrument-based

Segmentation by application:

- Breast Cancer

- Lung Cancer

- Colorectal Cancer

- Melanoma

- Others

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- Becton, Dickinson and Company

- GE Healthcare

- Abbott

- Roche

- Thermo Fisher Scientific, Inc.

- Agilent Technologies, Inc.

- Illumina, Inc.

- Siemens Healthcare

- C.R. Bard, Inc.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Cancer Diagnostics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Cancer Diagnostics market by identifying its various subsegments.

- Focuses on the key global Cancer Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Cancer Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Cancer Diagnostics submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Cancer Diagnostics Market Growth 2018-2023

Table of Contents

2018-2023 Global Cancer Diagnostics Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Diagnostics Consumption 2013-2023
2.1.2 Cancer Diagnostics Consumption CAGR by Region
2.2 Cancer Diagnostics Segment by Type
2.2.1 Platform-based
2.2.2 Instrument-based
2.3 Cancer Diagnostics Consumption by Type
2.3.1 Global Cancer Diagnostics Consumption Market Share by Type (2013-2018)
2.3.2 Global Cancer Diagnostics Revenue and Market Share by Type (2013-2018)
2.3.3 Global Cancer Diagnostics Sale Price by Type (2013-2018)
2.4 Cancer Diagnostics Segment by Application
2.4.1 Breast Cancer
2.4.2 Lung Cancer
2.4.3 Colorectal Cancer
2.4.4 Melanoma
2.4.5 Others
2.5 Cancer Diagnostics Consumption by Application
2.5.1 Global Cancer Diagnostics Consumption Market Share by Application (2013-2018)
2.5.2 Global Cancer Diagnostics Value and Market Share by Application (2013-2018)
2.5.3 Global Cancer Diagnostics Sale Price by Application (2013-2018)

3 Global Cancer Diagnostics by Players
3.1 Global Cancer Diagnostics Sales Market Share by Players
3.1.1 Global Cancer Diagnostics Sales by Players (2016-2018)
3.1.2 Global Cancer Diagnostics Sales Market Share by Players (2016-2018)
3.2 Global Cancer Diagnostics Revenue Market Share by Players
3.2.1 Global Cancer Diagnostics Revenue by Players (2016-2018)
3.2.2 Global Cancer Diagnostics Revenue Market Share by Players (2016-2018)
3.3 Global Cancer Diagnostics Sale Price by Players
3.4 Global Cancer Diagnostics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Cancer Diagnostics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Cancer Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Cancer Diagnostics by Regions
4.1 Cancer Diagnostics by Regions
4.1.1 Global Cancer Diagnostics Consumption by Regions
4.1.2 Global Cancer Diagnostics Value by Regions
4.2 Americas Cancer Diagnostics Consumption Growth
4.3 APAC Cancer Diagnostics Consumption Growth
4.4 Europe Cancer Diagnostics Consumption Growth
4.5 Middle East & Africa Cancer Diagnostics Consumption Growth

5 Americas
5.1 Americas Cancer Diagnostics Consumption by Countries
5.1.1 Americas Cancer Diagnostics Consumption by Countries (2013-2018)
5.1.2 Americas Cancer Diagnostics Value by Countries (2013-2018)
5.2 Americas Cancer Diagnostics Consumption by Type
5.3 Americas Cancer Diagnostics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Cancer Diagnostics Consumption by Countries
6.1.1 APAC Cancer Diagnostics Consumption by Countries (2013-2018)
6.1.2 APAC Cancer Diagnostics Value by Countries (2013-2018)
6.2 APAC Cancer Diagnostics Consumption by Type
6.3 APAC Cancer Diagnostics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Cancer Diagnostics by Countries
7.1.1 Europe Cancer Diagnostics Consumption by Countries (2013-2018)
7.1.2 Europe Cancer Diagnostics Value by Countries (2013-2018)
7.2 Europe Cancer Diagnostics Consumption by Type
7.3 Europe Cancer Diagnostics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Cancer Diagnostics by Countries
8.1.1 Middle East & Africa Cancer Diagnostics Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Cancer Diagnostics Value by Countries (2013-2018)
8.2 Middle East & Africa Cancer Diagnostics Consumption by Type
8.3 Middle East & Africa Cancer Diagnostics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Cancer Diagnostics Distributors
10.3 Cancer Diagnostics Customer

11 Global Cancer Diagnostics Market Forecast
11.1 Global Cancer Diagnostics Consumption Forecast (2018-2023)
11.2 Global Cancer Diagnostics Forecast by Regions
11.2.1 Global Cancer Diagnostics Forecast by Regions (2018-2023)
11.2.2 Global Cancer Diagnostics Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Cancer Diagnostics Forecast by Type
11.8 Global Cancer Diagnostics Forecast by Application

12 Key Players Analysis
12.1 Becton, Dickinson and Company
12.1.1 Company Details
12.1.2 Cancer Diagnostics Product Offered
12.1.3 Becton, Dickinson and Company Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Becton, Dickinson and Company News
12.2 GE Healthcare
12.2.1 Company Details
12.2.2 Cancer Diagnostics Product Offered
12.2.3 GE Healthcare Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 GE Healthcare News
12.3 Abbott
12.3.1 Company Details
12.3.2 Cancer Diagnostics Product Offered
12.3.3 Abbott Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Abbott News
12.4 Roche
12.4.1 Company Details
12.4.2 Cancer Diagnostics Product Offered
12.4.3 Roche Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Roche News
12.5 Thermo Fisher Scientific, Inc.
12.5.1 Company Details
12.5.2 Cancer Diagnostics Product Offered
12.5.3 Thermo Fisher Scientific, Inc. Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Thermo Fisher Scientific, Inc. News
12.6 Agilent Technologies, Inc.
12.6.1 Company Details
12.6.2 Cancer Diagnostics Product Offered
12.6.3 Agilent Technologies, Inc. Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Agilent Technologies, Inc. News
12.7 Illumina, Inc.
12.7.1 Company Details
12.7.2 Cancer Diagnostics Product Offered
12.7.3 Illumina, Inc. Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Illumina, Inc. News
12.8 Siemens Healthcare
12.8.1 Company Details
12.8.2 Cancer Diagnostics Product Offered
12.8.3 Siemens Healthcare Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Siemens Healthcare News
12.9 C.R. Bard, Inc.
12.9.1 Company Details
12.9.2 Cancer Diagnostics Product Offered
12.9.3 C.R. Bard, Inc. Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 C.R. Bard, Inc. News

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Cancer Diagnostics
Table Product Specifications of Cancer Diagnostics
Figure Cancer Diagnostics Report Years Considered
Figure Market Research Methodology
Figure Global Cancer Diagnostics Consumption Growth Rate 2013-2023 (K Units)
Figure Global Cancer Diagnostics Value Growth Rate 2013-2023 ($ Millions)
Table Cancer Diagnostics Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Platform-based
Table Major Players of Platform-based
Figure Product Picture of Instrument-based
Table Major Players of Instrument-based
Table Global Consumption Sales by Type (2013-2018)
Table Global Cancer Diagnostics Consumption Market Share by Type (2013-2018)
Figure Global Cancer Diagnostics Consumption Market Share by Type (2013-2018)
Table Global Cancer Diagnostics Revenue by Type (2013-2018) ($ million)
Table Global Cancer Diagnostics Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Cancer Diagnostics Value Market Share by Type (2013-2018)
Table Global Cancer Diagnostics Sale Price by Type (2013-2018)
Figure Cancer Diagnostics Consumed in Breast Cancer
Figure Global Cancer Diagnostics Market: Breast Cancer (2013-2018) (K Units)
Figure Global Cancer Diagnostics Market: Breast Cancer (2013-2018) ($ Millions)
Figure Global Breast Cancer YoY Growth ($ Millions)
Figure Cancer Diagnostics Consumed in Lung Cancer
Figure Global Cancer Diagnostics Market: Lung Cancer (2013-2018) (K Units)
Figure Global Cancer Diagnostics Market: Lung Cancer (2013-2018) ($ Millions)
Figure Global Lung Cancer YoY Growth ($ Millions)
Figure Cancer Diagnostics Consumed in Colorectal Cancer
Figure Global Cancer Diagnostics Market: Colorectal Cancer (2013-2018) (K Units)
Figure Global Cancer Diagnostics Market: Colorectal Cancer (2013-2018) ($ Millions)
Figure Global Colorectal Cancer YoY Growth ($ Millions)
Figure Cancer Diagnostics Consumed in Melanoma
Figure Global Cancer Diagnostics Market: Melanoma (2013-2018) (K Units)
Figure Global Cancer Diagnostics Market: Melanoma (2013-2018) ($ Millions)
Figure Global Melanoma YoY Growth ($ Millions)
Figure Cancer Diagnostics Consumed in Others
Figure Global Cancer Diagnostics Market: Others (2013-2018) (K Units)
Figure Global Cancer Diagnostics Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Cancer Diagnostics Consumption Market Share by Application (2013-2018)
Figure Global Cancer Diagnostics Consumption Market Share by Application (2013-2018)
Table Global Cancer Diagnostics Value by Application (2013-2018)
Table Global Cancer Diagnostics Value Market Share by Application (2013-2018)
Figure Global Cancer Diagnostics Value Market Share by Application (2013-2018)
Table Global Cancer Diagnostics Sale Price by Application (2013-2018)
Table Global Cancer Diagnostics Sales by Players (2016-2018) (K Units)
Table Global Cancer Diagnostics Sales Market Share by Players (2016-2018)
Figure Global Cancer Diagnostics Sales Market Share by Players in 2016
Figure Global Cancer Diagnostics Sales Market Share by Players in 2017
Table Global Cancer Diagnostics Revenue by Players (2016-2018) ($ Millions)
Table Global Cancer Diagnostics Revenue Market Share by Players (2016-2018)
Figure Global Cancer Diagnostics Revenue Market Share by Players in 2016
Figure Global Cancer Diagnostics Revenue Market Share by Players in 2017
Table Global Cancer Diagnostics Sale Price by Players (2016-2018)
Figure Global Cancer Diagnostics Sale Price by Players in 2017
Table Global Cancer Diagnostics Manufacturing Base Distribution and Sales Area by Players
Table Players Cancer Diagnostics Products Offered
Table Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Cancer Diagnostics Consumption by Regions 2013-2018 (K Units)
Table Global Cancer Diagnostics Consumption Market Share by Regions 2013-2018
Figure Global Cancer Diagnostics Consumption Market Share by Regions 2013-2018
Table Global Cancer Diagnostics Value by Regions 2013-2018 ($ Millions)
Table Global Cancer Diagnostics Value Market Share by Regions 2013-2018
Figure Global Cancer Diagnostics Value Market Share by Regions 2013-2018
Figure Americas Cancer Diagnostics Consumption 2013-2018 (K Units)
Figure Americas Cancer Diagnostics Value 2013-2018 ($ Millions)
Figure APAC Cancer Diagnostics Consumption 2013-2018 (K Units)
Figure APAC Cancer Diagnostics Value 2013-2018 ($ Millions)
Figure Europe Cancer Diagnostics Consumption 2013-2018 (K Units)
Figure Europe Cancer Diagnostics Value 2013-2018 ($ Millions)
Figure Middle East & Africa Cancer Diagnostics Consumption 2013-2018 (K Units)
Figure Middle East & Africa Cancer Diagnostics Value 2013-2018 ($ Millions)
Table Americas Cancer Diagnostics Consumption by Countries (2013-2018) (K Units)
Table Americas Cancer Diagnostics Consumption Market Share by Countries (2013-2018)
Figure Americas Cancer Diagnostics Consumption Market Share by Countries in 2017
Table Americas Cancer Diagnostics Value by Countries (2013-2018) ($ Millions)
Table Americas Cancer Diagnostics Value Market Share by Countries (2013-2018)
Figure Americas Cancer Diagnostics Value Market Share by Countries in 2017
Table Americas Cancer Diagnostics Consumption by Type (2013-2018) (K Units)
Table Americas Cancer Diagnostics Consumption Market Share by Type (2013-2018)
Figure Americas Cancer Diagnostics Consumption Market Share by Type in 2017
Table Americas Cancer Diagnostics Consumption by Application (2013-2018) (K Units)
Table Americas Cancer Diagnostics Consumption Market Share by Application (2013-2018)
Figure Americas Cancer Diagnostics Consumption Market Share by Application in 2017
Figure United States Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure United States Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Figure Canada Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure Canada Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Figure Mexico Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure Mexico Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Table APAC Cancer Diagnostics Consumption by Countries (2013-2018) (K Units)
Table APAC Cancer Diagnostics Consumption Market Share by Countries (2013-2018)
Figure APAC Cancer Diagnostics Consumption Market Share by Countries in 2017
Table APAC Cancer Diagnostics Value by Countries (2013-2018) ($ Millions)
Table APAC Cancer Diagnostics Value Market Share by Countries (2013-2018)
Figure APAC Cancer Diagnostics Value Market Share by Countries in 2017
Table APAC Cancer Diagnostics Consumption by Type (2013-2018) (K Units)
Table APAC Cancer Diagnostics Consumption Market Share by Type (2013-2018)
Figure APAC Cancer Diagnostics Consumption Market Share by Type in 2017
Table APAC Cancer Diagnostics Consumption by Application (2013-2018) (K Units)
Table APAC Cancer Diagnostics Consumption Market Share by Application (2013-2018)
Figure APAC Cancer Diagnostics Consumption Market Share by Application in 2017
Figure China Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure China Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Figure Japan Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure Japan Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Figure Korea Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure Korea Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Figure India Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure India Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Figure Australia Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure Australia Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Table Europe Cancer Diagnostics Consumption by Countries (2013-2018) (K Units)
Table Europe Cancer Diagnostics Consumption Market Share by Countries (2013-2018)
Figure Europe Cancer Diagnostics Consumption Market Share by Countries in 2017
Table Europe Cancer Diagnostics Value by Countries (2013-2018) ($ Millions)
Table Europe Cancer Diagnostics Value Market Share by Countries (2013-2018)
Figure Europe Cancer Diagnostics Value Market Share by Countries in 2017
Table Europe Cancer Diagnostics Consumption by Type (2013-2018) (K Units)
Table Europe Cancer Diagnostics Consumption Market Share by Type (2013-2018)
Figure Europe Cancer Diagnostics Consumption Market Share by Type in 2017
Table Europe Cancer Diagnostics Consumption by Application (2013-2018) (K Units)
Table Europe Cancer Diagnostics Consumption Market Share by Application (2013-2018)
Figure Europe Cancer Diagnostics Consumption Market Share by Application in 2017
Figure Germany Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure Germany Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Figure France Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure France Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Figure UK Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure UK Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Figure Italy Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure Italy Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Figure Russia Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure Russia Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Figure Spain Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure Spain Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Cancer Diagnostics Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Cancer Diagnostics Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Cancer Diagnostics Consumption Market Share by Countries in 2017
Table Middle East & Africa Cancer Diagnostics Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Cancer Diagnostics Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Cancer Diagnostics Value Market Share by Countries in 2017
Table Middle East & Africa Cancer Diagnostics Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Cancer Diagnostics Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Cancer Diagnostics Consumption Market Share by Type in 2017
Table Middle East & Africa Cancer Diagnostics Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Cancer Diagnostics Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Cancer Diagnostics Consumption Market Share by Application in 2017
Figure Egypt Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure Egypt Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Figure South Africa Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure South Africa Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Figure Israel Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure Israel Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Figure Turkey Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure Turkey Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Cancer Diagnostics Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Cancer Diagnostics Value Growth 2013-2018 ($ Millions)
Table Cancer Diagnostics Distributors List
Table Cancer Diagnostics Customer List
Figure Global Cancer Diagnostics Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Cancer Diagnostics Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Cancer Diagnostics Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Cancer Diagnostics Consumption Market Forecast by Regions
Table Global Cancer Diagnostics Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Cancer Diagnostics Value Market Share Forecast by Regions
Figure Americas Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Americas Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure APAC Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure APAC Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure Europe Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Europe Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure Middle East & Africa Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Middle East & Africa Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure United States Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure United States Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure Canada Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Canada Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure Mexico Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Mexico Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure Brazil Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Brazil Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure China Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure China Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure Japan Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Japan Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure Korea Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Korea Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure Southeast Asia Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Southeast Asia Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure India Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure India Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure Australia Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Australia Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure Germany Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Germany Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure France Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure France Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure UK Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure UK Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure Italy Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Italy Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure Russia Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Russia Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure Spain Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Spain Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure Egypt Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Egypt Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure South Africa Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure South Africa Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure Israel Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Israel Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure Turkey Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure Turkey Cancer Diagnostics Value 2018-2023 ($ Millions)
Figure GCC Countries Cancer Diagnostics Consumption 2018-2023 (K Units)
Figure GCC Countries Cancer Diagnostics Value 2018-2023 ($ Millions)
Table Global Cancer Diagnostics Consumption Forecast by Type (2018-2023) (K Units)
Table Global Cancer Diagnostics Consumption Market Share Forecast by Type (2018-2023)
Table Global Cancer Diagnostics Value Forecast by Type (2018-2023) ($ Millions)
Table Global Cancer Diagnostics Value Market Share Forecast by Type (2018-2023)
Table Global Cancer Diagnostics Consumption Forecast by Application (2018-2023) (K Units)
Table Global Cancer Diagnostics Consumption Market Share Forecast by Application (2018-2023)
Table Global Cancer Diagnostics Value Forecast by Application (2018-2023) ($ Millions)
Table Global Cancer Diagnostics Value Market Share Forecast by Application (2018-2023)
Table Becton, Dickinson and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Becton, Dickinson and Company Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Becton, Dickinson and Company Cancer Diagnostics Market Share (2016-2018)
Table GE Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GE Healthcare Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GE Healthcare Cancer Diagnostics Market Share (2016-2018)
Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Abbott Cancer Diagnostics Market Share (2016-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Roche Cancer Diagnostics Market Share (2016-2018)
Table Thermo Fisher Scientific, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Thermo Fisher Scientific, Inc. Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Thermo Fisher Scientific, Inc. Cancer Diagnostics Market Share (2016-2018)
Table Agilent Technologies, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Agilent Technologies, Inc. Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Agilent Technologies, Inc. Cancer Diagnostics Market Share (2016-2018)
Table Illumina, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Illumina, Inc. Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Illumina, Inc. Cancer Diagnostics Market Share (2016-2018)
Table Siemens Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Siemens Healthcare Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Siemens Healthcare Cancer Diagnostics Market Share (2016-2018)
Table C.R. Bard, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table C.R. Bard, Inc. Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure C.R. Bard, Inc. Cancer Diagnostics Market Share (2016-2018)
  • Global and China Checkpoint Inhibitors for Treating Cancer Market Research by Company, Type & Application 2013-2025
    Published: 16-Aug-2019        Price: US 2000 Onwards        Pages: 74
    Summary Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the "brakes" on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-......
  • Global Cancer Diagnostics Market Analysis: Emerging Opportunities in the USA, Europe, Japan--Supplier Shares and Strategies, Latest Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation
    Published: 13-Aug-2019        Price: US 28500 Onwards        Pages: 1200
    LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Japan; reviews current and emerging assays; analyzes potential applications of new diagnostic Technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportuniti......
  • France Cancer Diagnostics Market Analysis: Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation
    Published: 13-Aug-2019        Price: US 4500 Onwards        Pages: 585
    VPGMarket's new report is a study of the major business opportunities emerging in the French cancer diagnostics market during the next five years.  The report examines trends in the French cancer diagnostics markets, reviews current and emerging assays; analyzes potential applications of new diagnostic Technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for supp......
  • Italy Cancer Diagnostics Market Analysis: Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation
    Published: 13-Aug-2019        Price: US 4500 Onwards        Pages: 570
    VPGMarketResearch’s new report is a study of the major business opportunities emerging in the Italian cancer diagnostics market during the next five years.  The report examines trends in the Italian cancer diagnostics markets, reviews current and emerging assays; analyzes potential applications of new diagnostic Technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opport......
  • Spain Cancer Diagnostics Market Analysis: Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation
    Published: 13-Aug-2019        Price: US 4500 Onwards        Pages: 565
    VPGMarketResearch’s new report is a study of the major business opportunities emerging in the Spanish cancer diagnostics market during the next five years.  The report examines trends in the Spanish cancer diagnostics markets, reviews current and emerging assays; analyzes potential applications of new diagnostic Technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opport......
  • US Cancer Diagnostics Market Analysis: Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation
    Published: 13-Aug-2019        Price: US 4500 Onwards        Pages: 620
    LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the U.S. cancer diagnostics market during the next five years.  The report examines trends in the U.S. cancer diagnostics markets, reviews current and emerging assays; analyzes potential applications of new diagnostic Technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunit......
  • World Cancer Diagnostics Market: Emerging Opportunities in the Americas, EMEA, APAC--A 75-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
    Published: 13-Aug-2019        Price: US 48500 Onwards        Pages: 1450
    This new 75-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years.......
  • Asia-Pacific Cancer Diagnostics Market: A 17-Country Analysis--Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
    Published: 13-Aug-2019        Price: US 14500 Onwards        Pages: 935
    This new 17-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years. The report provides granular market segmentation analy......
  • Europe Cancer Diagnostics Market: A 31-Country Analysis--Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
    Published: 13-Aug-2019        Price: US 27500 Onwards        Pages: 935
    This new 31-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years. The report provides granular market segmentation analy......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs